V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20209498 | 20078081 | 0 | 0 | Palliative (P) | 2017-11-27 | 2017-12-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101153078 |
| 20209501 | 20078082 | 1.73 | 62.55 | Palliative (P) | 2019-12-17 | 2019-12-25 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101754381 |
| 20209505 | 20078083 | 1.5 | 79.2 | null | null | 2018-06-04 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100189545 |
| 20209510 | 20078084 | null | null | Palliative (P) | 2017-04-30 | 2017-05-17 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100330167 |
| 20209517 | 20078085 | 1.68 | 57.5 | Neo-adjuvant (N) | 2019-05-10 | 2019-05-11 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100300985 |
| 20209519 | 20078086 | 1.82 | 90.4 | Curative (C) | 2017-10-18 | 2017-10-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100649856 |
| 20209520 | 20078087 | null | 64.2 | Palliative (P) | 2021-03-17 | 2021-04-16 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101135290 |
| 20209524 | 20078088 | 0 | 0 | Palliative (P) | 2018-06-26 | 2018-06-28 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100632765 |
| 20209526 | 20078089 | null | 77.1 | Palliative (P) | 2019-07-30 | 2019-08-04 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100164938 |
| 20209533 | 20078090 | null | 54.4 | Palliative (P) | 2016-07-22 | 2016-07-27 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100866521 |
| 20209534 | 20078091 | 0 | 0 | Palliative (P) | 2016-10-08 | 2016-10-26 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100953834 |
| 20209537 | 20078092 | 1.69 | 75 | Palliative (P) | 2019-07-20 | 2019-09-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100252859 |
| 20209542 | 20078093 | 1.56 | 95.4 | Disease modification (D) | 2018-03-17 | 2018-03-29 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101151369 |
| 20209547 | 20078094 | 1.81 | 44 | Curative (C) | 2017-03-12 | 2017-04-01 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 100469916 |
| 20209548 | 20078095 | 1.75 | 84.5 | Palliative (P) | 2019-05-10 | 2019-05-11 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100554038 |
| 20209549 | 20078096 | 1.69 | 73 | Palliative (P) | 2019-03-10 | 2019-03-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101688674 |
| 20209552 | 20078097 | 1.52 | 100.8 | Curative (C) | 2018-02-08 | 2018-02-13 | Capecitabine (14 days)+Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101477762 |
| 20209558 | 20078098 | 1.6 | 50.7 | Palliative (P) | 2019-09-03 | 2019-09-17 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100910086 |
| 20209559 | 20078099 | 1.53 | 87.1 | Palliative (P) | 2017-07-08 | 2017-07-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101350468 |
| 20209565 | 20078100 | 1.71 | 75 | Palliative (P) | 2018-11-11 | 2018-11-16 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101179131 |
| 20209571 | 20078101 | 1.82 | 43.6 | Palliative (P) | 2018-08-29 | 2018-09-27 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100856899 |
| 20209579 | 20078102 | 1.65 | 51 | null | 2018-06-10 | 2018-06-15 | CISPLATIN + FLUOROURACIL + RT | N | null | CISPLATIN + FLUOROURACIL | 100227259 |
| 20209594 | 20078103 | 0 | 0 | Neo-adjuvant (N) | 2017-02-01 | 2017-02-20 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101320467 |
| 20209595 | 20078104 | 1.72 | 62 | Palliative (P) | 2017-03-28 | 2017-04-09 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100195453 |
| 20209606 | 20078105 | 1.61 | 45.6 | Curative (C) | 2019-03-07 | 2019-03-07 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100750748 |
| 20209617 | 20078106 | 1.69 | 40.6 | Palliative (P) | 2018-03-08 | 2018-03-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100885662 |
| 20209624 | 20078107 | null | null | Palliative (P) | 2018-04-15 | 2018-04-15 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101427367 |
| 20209631 | 20078108 | 1.55 | 75.2 | Neo-adjuvant (N) | 2019-03-29 | 2019-04-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101097701 |
| 20209636 | 20078109 | 1.53 | 59.35 | Neo-adjuvant (N) | 2016-12-15 | 2016-12-19 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101038482 |
| 20209637 | 20078110 | 1.75 | 66.7 | Palliative (P) | 2019-02-23 | 2019-03-09 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101213807 |
| 20209644 | 20078111 | 1.58 | 124 | Adjuvant (A) | 2018-06-03 | 2018-06-03 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101226004 |
| 20209649 | 20078112 | 1.8 | 81.8 | Adjuvant (A) | 2018-02-10 | 2018-02-25 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101265857 |
| 20209653 | 20078113 | 1.6 | 72.5 | Neo-adjuvant (N) | 2018-09-18 | 2018-09-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101565522 |
| 20209654 | 20078114 | 1.7 | 68.1 | Palliative (P) | 2018-07-06 | 2018-07-14 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100456642 |
| 20209661 | 20078115 | 1.74 | 76.5 | Palliative (P) | 2019-10-31 | 2019-11-03 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100662110 |
| 20209672 | 20078116 | 0 | 0 | null | 2016-03-04 | 2016-04-07 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100632096 |
| 20209674 | 20078117 | 1.67 | 88.9 | Neo-adjuvant (N) | 2018-12-08 | 2018-12-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101552125 |
| 20209685 | 20078118 | 1.65 | 66.9 | Neo-adjuvant (N) | 2019-08-02 | 2019-08-08 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101516068 |
| 20209691 | 20078119 | 1.52 | 71.8 | Palliative (P) | 2019-10-25 | 2019-11-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100329820 |
| 20209694 | 20078120 | null | null | Palliative (P) | 2021-05-15 | 2021-06-15 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100206606 |
| 20209695 | 20078121 | 1.76 | 73.1 | Palliative (P) | 2017-03-02 | 2017-03-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101284232 |
| 20209699 | 20078122 | 1.71 | 82.15 | Adjuvant (A) | 2019-12-13 | 2019-12-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100436686 |
| 20209700 | 20078123 | 1.7 | 80.1 | Curative (C) | 2018-03-24 | 2018-03-31 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100939135 |
| 20209704 | 20078124 | 1.63 | 67.6 | Curative (C) | 2019-02-12 | 2019-03-09 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101729886 |
| 20209705 | 20078125 | 1.6 | 60.3 | Palliative (P) | 2017-05-21 | 2017-05-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101417591 |
| 20209708 | 20078126 | 1.64 | 89 | Palliative (P) | 2019-10-26 | 2019-11-17 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100750312 |
| 20209717 | 20078127 | 1.82 | 71.6 | Palliative (P) | 2019-08-13 | 2019-08-13 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100885868 |
| 20209718 | 20078128 | 0 | 0 | Neo-adjuvant (N) | 2018-01-01 | 2018-02-01 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100932421 |
| 20209721 | 20078129 | 1.74 | 76.5 | Curative (C) | 2017-07-11 | 2017-07-22 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 101409439 |
| 20209728 | 20078130 | 1.49 | 65.8 | Palliative (P) | 2017-07-16 | 2017-08-03 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 101258155 |